A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial

OBJECTIVE: To assess whether three novel interventions, formulated based on a systems medicine therapeutic concept, reduced disease activity in patients with relapsing–remitting multiple sclerosis (MS) who were either treated or not with disease-modifying treatment. DESIGN: A 30-month randomised, do...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantzaris, Marios C, Loukaides, George N, Ntzani, Evangelia E, Patrikios, Ioannis S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Nutrition and Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641495/
https://www.ncbi.nlm.nih.gov/pubmed/23599375
http://dx.doi.org/10.1136/bmjopen-2012-002170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641495/
https://www.ncbi.nlm.nih.gov/pubmed/23599375
http://dx.doi.org/10.1136/bmjopen-2012-002170

Ejemplares similares